Dermaliq Therapeutics, Inc. (Dermaliq) today announces that Ralf Paus, M.D., D.Sc., F.R.S.B. has joined the company’s Scientific and Medical Advisory Board.

Mallia Therapeutics & Northway Biotech partner to manufacture soluble CD83 protein for hair loss treatment: Erlangen, Germany Wednesday, February 5, 2025, 15:00 Hrs [IST] Mallia T ...

A dermatologist is a medical doctor who specializes in treating the skin, hair, and nails. Dermatologists care for people of all ages. Hair can play a big role in a person’s identity or culture, so ...

Interestingly, sCD83's mode of action induces both the formation of new hair follicles and thus hair growth, and has the potential to redefine treatment approaches for hormone-induced androgenetic ...

Key Takeaways Spironolactone is effective for both premenopausal and postmenopausal women Finasteride is primarily used for ...

Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

Even if you're not dealing with hair loss or shedding, rosemary oil products can still deliver some ingredient benefits to ...